TGTX
TG Therapeutics Inc
58.10$
+1.7%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 36,664.0% | 41,551.8% | 51,881.8% | 77,950.0% | 57.9% | 185.5% | 246.1% | 11.8% | 9.5% | 6.0% | 11.7% | 16.3% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 42.1% | 100.0% | 100.0% | 88.2% | 90.5% | 94.0% | 88.3% | 83.7% | |
| 20,576.6% | 28,511.3% | 43,633.9% | 63,581.5% | 101,179.6% | 101,434.2% | 109,142.1% | 3,327.5% | 4,501.0% | 32.6% | 28.7% | 26.0% | |
| 10,360.3% | 10,254.0% | 8,289.5% | 14,423.1% | 9,974.3% | 9,886.2% | 70,953.9% | 1,914.9% | 3,428.5% | 52.5% | 46.9% | 37.7% | |
| 36,667.0% | 41,561.9% | 51,923.5% | 78,004.6% | 114,836.8% | 111,320.4% | 180,096.1% | 5,242.5% | 7,929.5% | 85.1% | 75.6% | 63.6% | |
| -36,567.0% | -41,461.9% | -51,823.5% | -77,904.6% | -114,736.8% | -111,220.4% | -179,996.1% | -5,154.3% | -7,839.0% | 8.8% | 12.7% | 20.0% | |
| 610.8% | 638.4% | 0.0% | 747.8% | 1,140.8% | 3,478.3% | 4,163.8% | 84.3% | 365.9% | 5.4% | 7.3% | 4.3% | |
| -36,606.5% | -41,310.0% | -51,353.4% | -77,749.9% | -114,132.9% | -113,730.9% | -183,803.3% | -5,204.1% | -8,036.3% | 5.6% | 7.8% | 17.4% | |
| 39.5% | -151.8% | -470.0% | -154.7% | -603.9% | 4,260.5% | 4,274.3% | 111.4% | 197.3% | 0.2% | 0.7% | -55.1% | |
| -36,606.5% | -41,310.0% | -51,353.4% | -77,749.9% | -114,132.9% | -113,730.9% | -183,803.3% | -5,204.1% | -8,036.3% | 5.4% | 7.1% | 72.6% | |
| -36,564.4% | -41,451.7% | -51,782.2% | -77,850.5% | -114,075.0% | -110,067.1% | -179,393.4% | -5,112.4% | -7,651.9% | 11.2% | 15.2% | 21.8% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.